Hokuyaku Takeyama Holdings, Inc operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hokuyaku Takeyama Holdings, Inc with three other
drug stores in Asia:
Immuno-Biological Laboratories Company Limited
sales of 758.29 million Japanese Yen [US$6.84 million]
Vital KSK Holdings Incorporation
(565.59 billion Japanese Yen [US$5.10 billion]
Toho Holdings Company Limited
(1.21 trillion Japanese Yen [US$10.94 billion]
During the year ended March of 2018, sales at
Hokuyaku Takeyama Holdings, Inc were ¥227.79 billion (US$2.05 billion).
decrease of 0.4%
versus 2017, when the company's sales were ¥228.71 billion.